Status:
COMPLETED
PROM Collected Via a Smartphone App Versus a Touch Screen Solution Among Patients With Inflammatory Arthritis
Lead Sponsor:
Salome Kristensen
Conditions:
Rheumatoid Arthritis
Psoriatic Arthritis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A randomised, within-participants cross-over design trial including 60 patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis. The participants will be randomised to data ...
Detailed Description
The study is a randomised, within-participants cross-over design trial including 60 patients with rheumatoid arthritis (RA) (20), psoriatic arthritis (PsA) (20) and axial spondyloarthritis (SpA) (20) ...
Eligibility Criteria
Inclusion
- A participant will be eligible for study participation if he/she meets the following criteria:
- Diagnosed in DANBIO with RA, PsA or SpA
- Is currently treated and monitored at the rheumatology outpatient clinic at Aalborg University Hospital
- Have previously reported PROM in DANBIO through the touch screen solution at the rheumatology outpatient clinic ≥ 3 times
Exclusion
- A participant cannot be included in the study if he/she meets any of the following criteria:
- Inability to provide informed consent or unwilling to comply with the study protocol
- Diagnosis of RA, PsA or SpA ≤ 12 months
- Does not have access to a smartphone that can download and run the DANBIO app
- Not able to understand written Danish i.e. cannot understand the Danish version of the PROM questionnaires
- Reduced sight in such degree that the participant cannot read the questionnaire in the smartphone app/on the touch-screen with e.g. glasses
Key Trial Info
Start Date :
April 24 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 12 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03486613
Start Date
April 24 2019
End Date
September 12 2019
Last Update
October 2 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Rheumatology
Aalborg, Denmark, 9000